Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to develop a better tolerated and more effective pharmacologic treatment for individuals with Asperger's Disorder and Pervasive Developmental Disorder. This is an open-label investigation of aripiprazole in the management of the maladaptive behaviors of autistic disorder. We hypothesize that aripiprazole will be effective for reducing aggression and repetitive behavior.


Clinical Trial Description

Pervasive developmental disorders (PDD) are characterized be severe impairments in social interaction and communication in addition to restricted patterns of interests and activities. Research suggests that a dysregulation of the dopamine and serotonin systems contributes to these interfering behaviors in individuals with PDD. After benefits of typical neuroleptics were reported in subjects with PDD's, research shifted to the atypical antipsychotics, which have been shown to be better tolerated and effective in this population. However, the atypical antipsychotics have also been associated with adverse effects. Thus there remains a need for a novel pharmacotherapy that would be safe and effective for children and adolescents with PDD's including Asperger's disorder and PDD Not Otherwise Specified (PDD NOS). We hypothesize that aripiprazole will be effective for reducing aggression and repetitive behavior. We also hypothesize that aripiprazole will be well tolerated, with low risk for extrapyramidal symptoms, hyperprolactinemia, weight gain, or corrected QT interval (QTc) prolongation. In addition, this open-label study will serve to stimulate more definitive, controlled research. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00198055
Study type Interventional
Source Indiana University
Contact
Status Completed
Phase Phase 2
Start date January 2005
Completion date September 2007

See also
  Status Clinical Trial Phase
Recruiting NCT01243905 - Group Psychoeducational Program for Mothers of Children With High Functional Pervasive Developmental Disorders Phase 2/Phase 3
Not yet recruiting NCT00531830 - Assessment of Factors Which Predict Improvement in Children With PDD After a Year of Integrative Therapy N/A
Completed NCT02985749 - A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder Phase 3
Terminated NCT00325572 - Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism Phase 1
Completed NCT00399698 - Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. Phase 3
Completed NCT03177590 - Recording Facial and Vocal Emotional Productions in Children With Autism as Part of the JEMImE Project N/A
Recruiting NCT05664841 - The Impact of a Virtual Magic Trick Training Program Phase 2
Active, not recruiting NCT02199925 - An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum Phase 4
Terminated NCT01553240 - Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies N/A
Completed NCT00464477 - Advanced Grandparental Age as a Risk Factor for Autism N/A
Active, not recruiting NCT03170453 - Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder N/A
Completed NCT00773812 - Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders Phase 1
Completed NCT01808066 - GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs N/A
Completed NCT00870727 - Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders Phase 3
Completed NCT00308074 - An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders Phase 2
Completed NCT00579267 - Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) N/A
Completed NCT04788537 - Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders N/A
Recruiting NCT04654260 - Behavior Therapy for Irritability in Autism N/A
Completed NCT01921244 - Shared Decision Making to Improve Care and Outcomes for Children With Autism N/A
Completed NCT00902798 - Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder N/A